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Abstract
Background: Early diagnosis of anaemia represents an important task within primary care settings. This study
reports on the frequency of new cases of anaemia among patients attending rural primary care settings in Crete
(Greece) and to offer an estimate of iron deficiency anaemia (IDA) frequency in this study group.
Methods: All patients attending the rural primary health care units of twelve general practitioners (GPs) on the
island of Crete for ten consecutive working days were eligible to participate in this study. Hemoglobin (Hb) levels
were measured by portable analyzers. Laboratory tests to confirm new cases of anaemia were performed at the
University General Hospital of Heraklion.
Results: One hundred and thirteen out of 541 recruited patients had a low value of Hb according to the initial
measurement obtained by the use of the portable analyzer. Forty five (45.5%) of the 99 subjects who underwent
laboratory testing had confirmed anaemia. The mean value of the Hb levels in the group with confirmed anaemia,
as detected by the portable analyzer was 11.1 g/dl (95% Confidence Interval (CI) from 10.9 to 11.4) and the
respective mean value of the Hb levels obtained from the full blood count was 11.4 g/dl (95% CI from 11.2 to
11.7) (P = 0.01). Sixteen out of those 45 patients with anaemia (35.6%) had IDA, with ferritin levels lower than 30
ng/ml.
Conclusion: Keeping in mind that this paper does not deal with specificity or sensitivity figures, it is suggested
that in rural and remote settings anaemia is still invisible and point of care testing may have a place to identify it.
Background
Anaemia is a common haematologic disorder which
increasingly occurs in older age groups and its onset is
usually insidious and slow [1]. As anemia worsens and
due to insufficient circulatory adaptive mechanisms in
the elderly, discomfort and functional impairment may
be progressively installed [1]. Approximately, 11.0% of
men and 10.2% of women ≥ 65 years are anaemic. One
third of the elderly patients with anaemia present nutri-
ent deficiencies, conditions which should be readily trea-
ted and cautiously linked with possible underlying
disorders [2].
Symptoms reported in general practice/family medi-
cine (GP/FM) play an important role in diagnosing
anaemia. Fatigue, palpitations, dyspnoea on exertion,
and poor concentration are some of the general symp-
toms related to anaemia, however they can be similarly
linked with cancer, thyroid disorders, angina pectoris,
and depression respectively [3-5]. Clinical signs like
cheilitis, hair loss, fragility of nails and even cognitive
impairment in many cases have been commonly asso-
ciated with anaemia [1,6-8]. Unexplained weight loss,
insisting bony pain and other atypical signs deserve to
be assessed so as to rule out malignancy or inflamma-
tion causes [1]. Diagnosis of anaemia in primary care
settings deserves attention and it is considered as essen-
tial task for GPs since it is frequently associated with
chronic illness. The most common cause of iron defi-
ciency anaemia (IDA) among those aged 50 and above
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tract [9]. Premenopausal women also have a high preva-
lence of IDA not only secondary to menstrual blood
loss but also due to low intake of dietary iron [10].
Inadequate absorption of iron is another well established
cause of IDA [11]. The presence of IDA can also be the
first sign of GI disorders including inflammatory bowel
diseases, celiac disease and atrophic gastritis [12,13].
Other known etiologies of IDA are intense physical
exercise, chronic diseases which are paired with inflam-
matory processes, and the intake of agents that can sub-
sequently interfere with the absorption of iron. In
general, unless there is a clinically obvious cause, occult
(GI) bleeding should always be considered, with studies
demonstrating GI abnormalities in 62%-90% of patients
[14,15].
Although, the diagnosis of anaemia is considered as
important in primary care, in a changing and uncertain
world where the health care budgets are increasingly
revisited, the need for an inexpensive and accurate diag-
nostic technology is becoming promising as option.
Although the use of near-patient testing (point-of-care
devices) is still a controversial issue introducing opposite
views between clinical practitioners and laboratory phy-
sicians it attracts the interest of academic and laboratory
researchers [16]. It seems that the use of such diagnostic
tools could lead to the identification of new cases of
anaemia or other conditions, earlier than usually identi-
fied [17]. In Greece, this seems to be rather neglected
and there is limited information that reports the burden
due to anaemia, and there are questions whether many
cases have been undiagnosed with anaemia among
patients visiting frequently rural primary care centers. It
is also worthy to discuss to what extent inexpensive
diagnostic tools can contribute to early diagnosis of
anaemia. Towards this direction a multisetting study on
anaemia diagnosis using a simple and low cost diagnos-
tic tool was designed in rural Crete [17].
The primary focus of this cross-sectional study was to
identify new cases of anaemia among patients in regular
contact with their GP in rural Crete. A secondary focus
was to explore the frequency of IDA among the new
cases of anaemia.
Methods
Setting
Between October and November 2009, all active mem-
bers (n = 17) of the recently developed practice-based
research network, coordinated by the Clinic of Social
and Family Medicine, School of Medicine, University of
Crete, were eligible and they were invited to participate
in this study [18]. Fourteen GPs from nine primary
health care units in Crete accepted this invitation. The
total population coverage of these primary care units
was estimated to be approximately 40,000 people.
Participants recruitment and sampling
All primary care users who were visiting the participat-
ing GPs in rural Crete, over ten consecutive working
days, were eligible to participate. Adult patients who
volunteered to participate in the research were
required to meet the following criteria: they were visit-
ing their GPs for a routine medical reason; they were
“known” to the GP (number of visits of each partici-
pating patient was at least two during the last year).
Patients who were already diagnosed with anaemia,
and those currently receiving treatment or who had
received treatment for anaemia within the last six
months were excluded from the study. Additionally,
patients who had a malignancy in their medical history
were excluded. The patients were fully informed by the
GP regarding the procedure and objectives of the
study and they were asked to give written consent for
their participation. Given an expected proportion of
anaemia in this population group (prevalence) of 10%
(Pr = 0.1), the sample size needed, with a precision of
3% (d = 0.03) and a 95% confidence level, is at least
384 [19].
Test methods
Blood collection was performed initially by finger prick
testing [20] in the GP practices, then if required by
venepuncture for laboratory investigation after providing
patients with detailed information on the procedures.
Hb was measured with the use of a portable device
(HemoCue 201). Well informed and trained GPs exe-
cuted the HemoCue test and read the results from this
portable device. For the patients who had possible anae-
mia according to the portable device measurements, an
appointment was arranged to collect blood samples on a
specific date (Figure 1). Anaemia was defined when the
Hb level (with the use of the portable analyzer) was <
13 g/dl in men or < 12 g/dl in women, in accordance
with the WHO criteria for detecting anaemia [21]. For
each of these patients, the laboratory investigations
r e q u e s t e di n c l u d e df u l lb l o o dc o u n ta n ds e r u mf e r r i t i n .
The testing of all samples took place in the Laboratory
of the University General Hospital of Heraklion (Beck-
man Coulter
® LH 780 Hematology Analyzer). Prior to
collection of samples, the researchers took instructions
regarding transport of samples from the various rural
sites within a suitable timeframe, as a precaution to
avoid sample degradation. IDA was diagnosed when the
Hb levels were < 13 g/dl in men or < 12 g/dl in women
in combination with levels of ferritin lower than 30 ng/
ml [22].
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The data obtained were tabulated in a Microsoft Excel
database and were then analysed with the use of SPSS 17.0
(SPSS Inc.; Chicago, IL, USA). Standard descriptive
statistics, including means, standard deviations, 95% Con-
fidence Intervals (CI) and frequency counts were used to
characterize the sample. Pair t-test was also performed. A
difference of P < 0.05 was considered significant.
Adults who are regularly 
examined and visit their 
GP for a routine reason 
and wish to participate; 
Recruitment over 10 
consecutive working days 
 
Completion of clinical 
information 
Measurement of 
haemoglobin using 
HemoCue 201 
Anaemia: 
 men <13mg/dl, 
women <12mg/dl 
 
Men >40 aged and 
postmenopausal 
women without “red-
flag”symptoms 
 
Men <40 aged and 
women in the 
reproductive age 
 
Further 
haematological 
investigations 
 
N=99 
 
Normal values: stop 
(Record of 
haemoglobin values) 
 
 
 
Confirmation of 
IDA (level of 
ferritin: <30ng/ml) 
 
N=16 
Patients with "red-
flag" symptoms: 
exclusion from our 
study and clinical 
management as it is 
necessary 
Figure 1 A flowchart summarizes the protocol developed for the detection of new cases of iron deficiency anaemia.
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T h i ss t u d yw a sd e s i g n e db yt h eC l i n i co fS o c i a la n d
Family Medicine and was approved by the Commission
of Bioethics of the University General Hospital of Her-
aklion (number of protocol: 4578, 07.05.2008). A writ-
ten, fully informed consent was obtained from all adult
patients enrolled into the study. All GPs and researchers
involved in this study signed an agreement that the pro-
tocol and the emerging information would be strictly
confidential.
Results
Participants
From the initial total number of GPs involved in the
study, two were excluded due to practical limitations
related to patient recruitment. Of the remaining twelve
participating GPs, a total of 541 patient attendees were
recruited, of whom 213 (39.4%) were males and 328
(60.6%) were females. The age groups represented in
higher frequencies were those of 70-79 years and 60-69
years (Figure 2). The collection of somatometric data
showed that mainly persons with a high Body Mass
Index participated in this study (Figure 3).
Anaemia tested at practice
The finger prick capillary sampling indicated 113
(20.9%) out of 541 study participants with possible anae-
mia; 45 of them were men (39.8%), and 68 were women
(60.2%). Of the 113 subjects with possible anaemia, 14
patients declined to further participate and the remain-
ing 99 patients (18.3% of the total sample) had blood
tests performed in the Laboratory of the University Gen-
eral Hospital of Heraklion. Forty five patients (45/99,
45.5%) (male to female ratio 1:2) were confirmed with
anaemia with a positive predictive value of the Hemo-
Cue test of 45.6%. The mean age of the men and
women with confirmed anaemia were 77.6 (SD: 4.9) and
67.1 (SD: 17.1) respectively.
Sixteen patients, (male to female ratio 1:3) had a ferri-
tin level lower than 30 ng/ml. The frequency of an IDA
diagnosis, based on the ferritin level, was 16.2% of those
who underwent laboratory testing and 3% of the initial
sample. Of the patients with IDA, the mean age for
males was 73.8 years (SD: 2.1) and for females was 59.2
years (SD: 21.6). The BMI of the male patients with
IDA was lower in comparison to the female patients
[24.5 (SD: 5.7) vs. 28.3 (SD: 7.2)].
Based on their medical history, the underlying causes
among patients with IDA, were possibly related to gas-
tric ulcer (1 case), colon polyp (1 case), rheumatoid
arthritis (2 cases), menstrual cycle disorder (5 cases) and
a prosthetic heart valve (1 case). An unclear explanation
of IDA status for 6 cases was recorded. During this
study, a new case of a male patient (85 years old) with a
proximal colon cancer was identified.
Estimates
In the group with confirmed anaemia, the mean value of
the Hb levels detected by the portable device was lower
than the mean value of the Hb levels obtained from the
full blood count [11.1 g/dl (95% CI from 10.9 to 11.4) vs
11.4 g/dl (95% CI from 11.2 to 11.7), (P = 0.01)]. Among
the 54 patients whose anaemic status was not confirmed
by laboratory testing, the mean value of the Hb levels
identified by the portable device was lower than the
mean value of the Hb levels based on the full blood
count [11.8 g/dl (95% CI from 11.6 to 12.0) vs 13.4 g/dl
(95% CI from 13.1 to 13.4), (P = 0.0001)]. For the IDA
patients, the mean value of the Hb levels detected by
the portable device analyzer was again lower than the
mean value of the Hb levels obtained from the full
blood count but without meeting statistical significance
[10.9 g/dl (95% CI from 10.5 to 11.3) vs 11.3 g/dl (95%
CI from 10.9 to 11.7), (P = 0.06)] (Table 1).
Discussion
Main findings
The main finding of this study was that it indicated 113
patients with possible anaemia, and 45 out of them were
identified as new cases with anaemia. Although the
3.1% 
9.8%  10.5%  9.4% 
24.2% 
30.1% 
12.8% 
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
Age Groups
18 - 29 years
30 - 39 years
40 - 49 years
50 - 59 years
60 - 69 years
70 - 79 years
шϴϬǇĞĂƌƐ 
Figure 2 Age of the participants.
1.8% 
20.9% 
39.4% 
37.7% 
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
40.0%
45.0%
Body Mass Index (BMI)
< 18.5 kg/m2
18.5 - 24.9 kg/m2
25 - 29.9 kg/m2
шϯϬŬŐͬŵϮ 
Figure 3 Body Mass Index (BMI) of the participants.
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nostic accuracy of the HemoCue device, 45% of those
identified as having anaemia by the portable device
indeed had anaemia. In the cases of confirmed anaemia
however, the portable device showed similar mean Hb
values to those of the full blood count.
Highlighting other findings
The 428 patients with negative readings using the porta-
ble device cannot be proven to be ‘not anaemic’. Bearing
in mind the technical difficulties and the high feasibility
of laboratory tests the 541 patients were not able to per-
form all extended exams. Thus, this study did not mea-
sure the specificity and in general the diagnostic
accuracy/reliability of this portable device. However the
specificity of the HemoCue 201 analyzer is reported to
be 94-95% in two recent studies [21,23]. Mendrone per-
formed the analysis of Hb with the use of the HemoCue
201 device on 969 potential female donors, and detected
a sensitivity of 56% and a specificity of 93.5%, with the
device being able to identify all those donors with anae-
mia who had Hb lower than 11.0 g/dL [21]. Eekhof and
Groeneveld used the HemoCue 201 device on 58
patients of two Dutch primary care units and they dis-
covered a higher sensitivity of 81% and a similar specifi-
city to the previous mentioned study, of 95% [23].
Future efforts are required to confirm if the returned
negative cases identified with this device are truly nega-
tive and to describe its overall utility in the local settings
by also introducing issues of cost analysis. Other bene-
fits of the portable device include the limited capacity
required to perform the test and immediacy of the
results [24].
Taking into consideration the 16 cases of IDA from an
initial group of 541, we estimate that the frequency of
new cases of IDA identified on the basis of this observa-
tory study was approximately 3%. Anaemia due to other
causes is expected to be approximately 6% (29/541
cases). Thus, the portable device can help to identify
subjects who may have a higher likelihood of anaemia.
One other interesting finding in our study is the high
prevalence of overweight and obesity patterns observed
in our sample. All patients who were included were
living in rural areas of Crete. It has been suggested from
a recent study that a high prevalence of increased body
weight trends was showed to occur among farmers in
the areas of rural Crete [25].
Strengths and limitations
With the use of this portable device we were able to
identify 45 cases of undetected anaemia. Certain limita-
tions interfered with the interpretation of the results of
this study. Firstly, as previously noted, for reasons of
financial cost we were limited to perform full laboratory
testing in all 541 patients involved in the study and,
consequently, to measure sensitivity, specificity, negative
predictive value and likehood ratios. Additionally it was
not possible to discuss cut offs of better performance of
the device. Another limitation is that the finger prick
capillary testing was performed at different practices by
different GPs, which may introduce a measurement bias.
As Conway et al. suggested, Hb measurement from sin-
gle skin-puncture drops can give rise to misleading
results [26]. Similarly, thev e n e p u n c t u r et o o kp l a c ei n
different practices, although this was conducted by a
single researcher. The venepuncture took place within
approximately 20 to 25 days from when the initial finger
prick testing was performed, a delay which was impossi-
b l et ob ea v o i d e dg i v e nt h er u r a ls e t t i n g ,b u tw h i c h
should not have introduced bias as the lifespan of a red
blood cell is longer than this interval [27]. Although this
is not a diagnostic accuracy study, several items of the
STARD checklist such as reporting the study popula-
tion, participant sampling, statistical and test methods
were followed [28].
Clinical applicability of the study results
Despite its visible limitations, this study raises some
important issues around investigation and diagnosis of
anaemia in rural and remote general practice settings. It
is demonstrated that the use of low cost portable analy-
sers may successfully lead to the diagnosis of new cases
of anaemia among regular primary care attendees. The
use of near to patient testing for anaemia with a porta-
ble device could also shorten the process of diagnosing
new cases of anaemia, thus allowing earlier therapeutic
Table 1 Mean values of the Hemoglobine of patients with a confirmed anaemia, patients with a false positive
diagnosis of anaemia, and patients with a confirmed iron deficiency anaemia
Hb value according the
portable device
Hb value according full blood count P - Value
Patients with a confirmed
anaemia (n = 45)
11.1 g/dl (95% Confidence
Interval (CI): 10.9-11.4)
11.4 g/dl (95% CI: 11.2-11.7) 0.01
Patients with a false
positive anaemia (n = 54)
11.8 g/dl (95% CI: 11.6-12.0) 13.4 g/dl (95% CI: 13.1-13.4) 0.0001
Patients with a confirmed Iron Deficiency Anaemia (n = 16) 10.9 g/dl (95% CI: 10.5-11.3) 11.3 g/dl (95% CI: 10.9-11.7) 0.06
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with an opportunity to make a proper referral for
further investigation for the confirmation of the anaemic
status of a patient, when the monitor of this device
shows low Hb values. The likelihood of receiving a posi-
tive confirmation for the anaemic status would also
increase when the information given by the clinical
examination supports the diagnosis of anaemia. Certain
questions are still unanswered based on the results of
this study and further research is needed.
Conclusions
From the study sample, 45% of those identified as hav-
ing anaemia by the portable device, indeed had anaemia.
To determine the probability that this device correctly
predicts true anaemia a study of diagnostic accuracy is
needed. Another conclusion of this study is that in rural
and isolated areas, anaemia is still ‘invisible’.I ta l s o
seems that an ordinary visit can offer the opportunity to
detect new cases of anaemia. This effort seems to be a
good start in a field where healthcare system capacity in
Greece is challenged by the current financial restrictions
and where barriers of access to health care are expected
to increase.
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